|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.45 INR | +4.78% |
|
+5.75% | +66.16% |
| 05-21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 05-20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.4B 67.79M 59.11M 54.74M 51.24M 96.11M 96.69M 649M 252M 3.15B 254M 249M 10.93B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.26B 76.94M 67.08M 62.13M 58.16M 109M 110M 737M 286M 3.57B 289M 283M 12.41B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.65% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | +4.78% | ||
| 1 week | +5.75% | ||
| Current month | +16.73% | ||
| 1 month | +19.45% | ||
| 3 months | +74.13% | ||
| 6 months | +69.12% | ||
| Current year | +66.16% |
| 1 week | 107 |  | 119.7 |
| 1 month | 98.5 | | 119.7 |
| Current year | 59.72 | | 119.7 |
| 1 year | 59.72 | | 126.95 |
| 3 years | 59.72 | | 151.75 |
| 5 years | 36.37 | | 151.75 |
| 10 years | 14 | | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 31/12/2001 |
| Director of Finance/CFO | - | 31/03/2019 | |
| Director of Finance/CFO | - | 31/12/1990 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 31/12/1989 |
| Director/Board Member | - | 31/12/1990 | |
Prakash Sapkal
BRD | Director/Board Member | - | 31/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.78% | +5.75% | +12.68% | +5.58% | 67.79M | |
| +0.74% | +1.69% | +10.40% | +85.32% | 46.74B | |
| -2.91% | +3.09% | +50.06% | +90.35% | 34.33B | |
| -0.27% | -2.71% | -9.86% | +33.69% | 11.57B | |
| -0.34% | -3.07% | +11.88% | +92.57% | 11.42B | |
| -0.57% | +0.96% | +37.43% | +128.26% | 9.09B | |
| +0.43% | -1.68% | +13.22% | +41.07% | 6.98B | |
| +2.77% | +1.83% | +35.25% | +243.81% | 6.62B | |
| -1.23% | +1.65% | +44.63% | -18.54% | 6.55B | |
| +0.73% | -2.94% | -35.25% | -2.32% | 5B | |
| Average | +0.41% | +0.65% | +17.04% | +69.98% | 13.84B | |
| Weighted average by Cap. | -0.44% | +1.00% | +21.75% | +82.89% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 40.18M 35.03M 32.45M 30.37M 56.96M 57.31M 385M 149M 1.87B 151M 148M 6.48B | 3.74B 39.68M 34.6M 32.04M 29.99M 56.25M 56.59M 380M 147M 1.84B 149M 146M 6.4B |
| Net income | 122M 1.29M 1.12M 1.04M 975K 1.83M 1.84M 12.35M 4.79M 59.88M 4.84M 4.74M 208M | 58.38M 619K 539K 500K 468K 877K 882K 5.93M 2.3M 28.74M 2.32M 2.27M 99.78M |
| Net Debt | 1.16B 12.27M 10.7M 9.91M 9.27M 17.39M 17.5M 118M 45.55M 570M 46.05M 45.06M 1.98B | 863M 9.15M 7.98M 7.39M 6.91M 12.97M 13.05M 87.62M 33.96M 425M 34.33M 33.6M 1.48B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 119.45 ₹ | +4.78% | 25,585 |
| 18/06/26 | 114.00 ₹ | +4.92% | 3,405 |
| 17/06/26 | 108.65 ₹ | +0.14% | 1,367 |
| 16/06/26 | 108.50 ₹ | -2.73% | 1,066 |
| 15/06/26 | 111.55 ₹ | -1.24% | 6,065 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
